Kailash Singh
Researcher at Department of Medical Cell Biology; Research Group Stellan Sandler
- E-mail:
- kailash.singh@mcb.uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA

Publications
Selection of publications
Diabetic complications and prospective immunotherapy
Part of Frontiers in Immunology, 2023
- DOI for Diabetic complications and prospective immunotherapy
- Download full text (pdf) of Diabetic complications and prospective immunotherapy
Part of International Journal of Molecular Sciences, 2022
- DOI for Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
- Download full text (pdf) of Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
Part of Biomolecules, 2022
- DOI for Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
- Download full text (pdf) of Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
Part of International Journal of Molecular Sciences, 2021
- DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
- Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
Part of Clinical and Experimental Immunology, p. 64-73, 2019
- DOI for Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
- Download full text (pdf) of Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide
Part of Diabetes Care, p. 1090-1095, 2017
Part of Scientific Reports, p. 7767, 2015
- DOI for Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
- Download full text (pdf) of Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
Part of Scientific Reports, 2015
- DOI for Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells
- Download full text (pdf) of Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells
Recent publications
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Frontiers in Microbiology, 2024
- DOI for Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota
- Download full text (pdf) of Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota
Diabetic complications and prospective immunotherapy
Part of Frontiers in Immunology, 2023
- DOI for Diabetic complications and prospective immunotherapy
- Download full text (pdf) of Diabetic complications and prospective immunotherapy
Part of International Journal of Molecular Sciences, 2022
- DOI for Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
- Download full text (pdf) of Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
Part of Biomolecules, 2022
- DOI for Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
- Download full text (pdf) of Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
All publications
Articles in journal
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Frontiers in Microbiology, 2024
- DOI for Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota
- Download full text (pdf) of Investigating the effects of radiation, T cell depletion, and bone marrow transplantation on murine gut microbiota
Part of International Journal of Molecular Sciences, 2022
- DOI for Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
- Download full text (pdf) of Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
Part of Biomolecules, 2022
- DOI for Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
- Download full text (pdf) of Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
Part of International Journal of Molecular Sciences, 2021
- DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
- Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
Significance of host heparanase in promoting tumor growth and metastasis
Part of Matrix Biology, p. 25-42, 2020
Part of Journal of Visualized Experiments, 2019
Part of Scientific Reports, 2019
- DOI for The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 1 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 2 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
Part of FASEB BioAdvances, p. 538-549, 2019
- DOI for Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
- Download full text (pdf) of Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
Part of Clinical and Experimental Immunology, p. 64-73, 2019
- DOI for Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
- Download full text (pdf) of Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
Part of Oncotarget, p. 18720-18733, 2018
- DOI for Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
- Download full text (pdf) of Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
Part of Scientific Reports, 2017
- DOI for Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis
- Download full text (pdf) of Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis
Kinetics of innate immune and regulatory T cells responses in experimental diabetic nephropathy
Part of Scandinavian Journal of Immunology, p. 304-304, 2017
Kinetics of the innate immune cell responses in experimental Type 1 Diabetes
Part of Scandinavian Journal of Immunology, p. 303-304, 2017
Part of Journal of Diabetes Research, 2017
- DOI for The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
- Download full text (pdf) of The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
Role of regulatory B cells in clinical and experimental type 1 diabetes
Part of Scandinavian Journal of Immunology, p. 349-349, 2017
Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide
Part of Diabetes Care, p. 1090-1095, 2017
Part of European Journal of Immunology, p. 1065-1065, 2016
Part of Scientific Reports, p. 7767, 2015
- DOI for Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
- Download full text (pdf) of Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
Part of Scientific Reports, 2015
- DOI for Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells
- Download full text (pdf) of Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells
Part of Journal of Biological Chemistry, p. 15121-15132, 2015
Part of Scandinavian Journal of Immunology, p. 447-447, 2014
Part of Scandinavian Journal of Immunology, p. 286-286, 2013
Part of Immunology, p. 26-26, 2012